Mount Sinai Logo

Uchechukwu Megwalu

  • ASSISTANT PROFESSOR Otolaryngology
Print ProfilePrint Profile

Education

  • BSc, McMaster University

  • Otolaryngology Residency, The New York Eye and Ear Infirmary

  • MPH, Icahn School of Medicine at Mount Sinai

  • MD, Washington University School of Medicine

Research

New topic

Outcomes research

Publications

Olarte LS, Megwalu UC. The Impact of Demographic and Socioeconomic Factors on Major Salivary Gland Cancer Survival. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2014 Mar; 150(6).

Megwalu UC. A systematic review of proton-pump inhibitor therapy for laryngopharyngeal reflux. Ear, nose, & throat journal 2013 Aug; 92(8).

Kamat A, Rajoria S, George A, Suriano R, Shanmugam A, Megwalu U, Prakash PB, Tiwari R, Schantz S. Estrogen-mediated angiogenesis in thyroid tumor microenvironment is mediated through VEGF signaling pathways. Archives of otolaryngology--head & neck surgery 2011 Nov; 137(11).

Megwalu UC, Shin EJ. Second primaries after major salivary gland cancer. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2011 Aug; 145(2).

Rajoria S, Suriano R, Parmar PS, Wilson YL, Megwalu U, Moscatello A, Bradlow HL, Sepkovic DW, Geliebter J, Schantz SP, Tiwari RK. 3,3'-diindolylmethane modulates estrogen metabolism in patients with thyroid proliferative disease: a pilot study. Thyroid : official journal of the American Thyroid Association 2011 Mar; 21(3).

Megwalu UC, Piccirillo JF. Methodological and statistical problems in uvulopalatopharyngoplasty research: a follow-up study. Archives of otolaryngology--head & neck surgery 2008 Aug; 134(8).

Megwalu UC, Finnell JE, Piccirillo JF. The effects of melatonin on tinnitus and sleep. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2006 Feb; 134(2).

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Megwalu did not report having any of the following types of financial relationships with industry during 2013 and/or 2014: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central